MedPath

INNOCOR as VAD Therapy Optimizatio

Not Applicable
Conditions
heart failure
Registration Number
DRKS00011608
Lead Sponsor
Medizinische Hochschule Hannover, Abteilung HTTG, OE 6210
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
40
Inclusion Criteria

LVAD, mental and physical capacity, 18-65 y

Exclusion Criteria

lung disease, orthopaedic disease and contra indications of ergometry

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
measurement cardiac output in the first session as baseline and as therapy efficiency before and after changing pumpspeed.
Secondary Outcome Measures
NameTimeMethod
Measuring quality of life prior to the session as a baseline and 4 weeks after the session with the EQ-5D
© Copyright 2025. All Rights Reserved by MedPath